The study of DNA methylation in urological cancer: Present and future;El estudio de la metilación del ADN en el cáncer urológico: Presente y futuro

Actas Urologicas Espanolas

Volumn 37, Issue 6, 2013, Pages 368-375

  Andres G ^a   Ashour, N ^b   Sanchez Chapado M ^c   Ropero, S ^b   Angulo, J C ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Epigenetics DNA methylation Methylation specific polymerase chain reaction Bladder cancer Prostate cancer Renal cancer Testicular cancer

Indexed keywords

DNA;

CPG ISLAND; DNA METHYLATION; FEMALE; FORECASTING; GENETICS; HUMAN; MALE; MALE GENITAL TRACT TUMOR; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SEMEN ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR GENE; URINALYSIS; URINARY TRACT CANCER; URINE;

CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; FORECASTING; GENES, NEOPLASM; GENITAL NEOPLASMS, MALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; SEMEN ANALYSIS; SENSITIVITY AND SPECIFICITY; URINALYSIS; UROLOGIC NEOPLASMS;

EID: 84878994487     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2013.03.001     Document Type: Short Survey

References (45)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer Statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. A.P. Feinberg, R. Ohlsson, and S. Henikoff The epigenetic progenitor origin of human cancer Nat Rev Genet 7 2006 21 33
4. T.K. Sharma s Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
5. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
6. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
7. M. Esteller Cancer epigenomics: DNA methylomes and histone-modification maps Nat Rev Gene 8 2007 286 298
8. M.F. Fraga, M. Herranz, J. Espada, E. Ballestar, M.F. Paz, and S. Ropero A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors Cancer Res 64 2004 5527 5534
9. M. Esteller, P.G. Corn, S.B. Baylin, and J.G. Herman A gene hypermethylation profile of human cancer Cancer Res 61 2001 3225 3229
10. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 1996 9821 9826
11. M. Frommer, L.E. McDonald, D.S. Millar, C.M. Collis, F. Watt, and G.W. Grigg A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands Proc Natl Acad Sci USA 89 1992 1827 1831
12. M. Quinn, and P. Babb Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons BJU Int 90 2002 162 173
13. M. Salagierski, and J.A. Schalken Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion J Urol 187 2012 795 801
14. D.S. Millar, K.K. Ow, C.L. Paul, P.J. Russell, P.L. Molloy, and S.J. Clark Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer Oncogene 18 1999 1313 1324
15. P. Cairns, M. Esteller, J.G. Herman, M. Schoenberg, C. Jeronimo, and M. Sanchez-Cespedes Molecular detection of prostate cancer in urine by GSTP1 hypermethylation Clin Cancer Res 7 2001 2727 2730
16. M.O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Roselbaum, and W. Van Criekinge Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects J Clin Oncol 23 2005 6569 6575
17. M. Roupret, V. Hupertan, D.R. Yates, J. Catto, I. Rehman, and M. Meuth Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage Clin Cancer Res 13 2007 1720 1725
18. T. Wu, E. Giovannucci, J. Welge, P. Mallick, W.Y. Tang, and S.M. Ho Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: A meta-analysis Br J Cancer 105 2011 65 73
19. Q. Wang, M. Williamson, S. Bott, N. Brookman-Amissah, A. Freeman, and J. Nariculam Hypomethylation of WNT5a, CRIP1 and S100P in prostate cancer Oncogene 26 2007 6560 6565
20. J. Baden, S. Adams, T. Astacio, J. Jones, J. Markiewicz, and J. Painter Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay J Urol 186 2011 2101 2106
21. H. Enokida, H. Shiina, S. Urakami, M. Igawa, T. Ogishima, and Li L.F C. Multigene methylation analysis for detection and staging of prostate cancer Clin Cancer Res 11 2005 6582 6588
22. N. Vasiljevic, A.S. Ahmad, C. Beesley, M.A. Thorat, G. Fisher, and M.D. Berney Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer Prostate Cancer Prostatic Dis. 16 2013 35 40 10.1038/pcan.2012.47
23. L.L. Bañez, L. Sun, G.J. van Leenders, T.M. Wheeler, C.H. Bangma, and S.J. Freedland Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer J Urol 184 2010 149 156
24. R.J. Sylvester, A.P. van der Meijden, W. Oosterlinck, J.A. Witjes, C. Bouffioux, and L. Denis Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: A combined analysis of 2,596 patients from seven EORTC trials Eur Urol 49 2006 466 477
25. C. Bolenz, A.M. West, N. Ortiz, W. Kabbani, and Y. Lotan Urinary cytology for the detection of urothelial carcinoma of the bladder - a flawed adjunct to cystoscopy? Urol Oncol. 31 2013 366 371 10.1016/j.urolonc.2011.01.017
26. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta Guía clínica del carcinoma urotelial de vejiga no músculo-invasivo de la Asociación Europea de Urología. Actualización de 2011 Actas Urol Esp 36 2012 389 402
27. T.C. Zuiverloon, W. Beukers, K.A. van der Keur, J.R. Muñoz, C.H. Bangma, and H.F. Lingsma A methylation assay for the detection of non-muscle- invasive bladder cancer (NMIBC) recurrences in voided urine BJU Int. 109 2012 941 948 10.1111/j.1464-410X.2011.10428.x
28. E. Dulaimi, R.G. Uzzo, R.E. Greenberg, T. Al-Saleem, and P. Cairns Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel Clin Cancer Res 10 2004 1887 1893
29. I. Renard, S. Joniau, B. van Cleynenbreugel, C. Collette, C. Naome, and I. Vlassenbroeck Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples Eur Urol 58 2010 96 104
30. T. Reinert, C. Modin, F.M. Castano, P. Lamy, T.K. Wojdacz, and L.L. Hansen Comprehensive genome methylation analysis in bladder cancer: Identification and validation of novel methylated genes and application of these as urinary tumor markers Clin Cancer Res 17 2011 5582 5592
31. R. Maruyama, S. Toyooka, K.O. Toyooka, K. Harada, A.K. Virmani, and S. Zöchbauer-Müller Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features Cancer Res 61 2001 8659 8663
32. C.J. Marsit, E.A. Houseman, B.C. Christensen, L. Gagne, M.R. Wrensch, and H.H. Nelson Identification of methylated genes associated with aggressive bladder cancer PLoS One 5 2010 e12334
33. M. Agundez, L. Grau, J. Palou, F. Algaba, H. Villavicencio, and M. Sanchez-Carbayo Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette- Guérin response in patients with T1G3 high-risk bladder tumours Eur Urol 60 2011 131 140
34. L. Frank, M.L. Blute, J.C. Cheville, C.M. Lohse, A.L. Weaver, and H. Zincke Solid renal tumors: Analysis of pathological features related to tumor size J Urol 170 2003 2217 2220
35. J.G. Herman, F. Latif, Y. Weng, M.I. Lerman, B. Zbar, and S. Liu Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci USA 91 1994 9700 9704
36. I. Ibanez de Caceres, and E. Dulaimi Identification of novel target genes by an epigenetic reactivation screen of renal cancer Cancer Res 66 2006 5021 5028
37. M.R. Morris, C.J. Ricketts, D. Gentle, F. McRonald, N. Carli, and H. Khalili Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma Oncogene 30 2011 1390 1401
38. C. Battagli, R.G. Uzzo, E. Dulaimi, I. Ibañez de Caceres, R. Krassentein, and T. Al-Saleem Promoter hypermethylation of tumor supressor genes in urine from kidney cancer patients Clin Can Res 63 2003 8695 8699
39. S. Urakami, H. Shiina, H. Enokida, H. Hirata, K. Kawamoto, and T. Kawakami Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA Clin Cancer Res 12 2006 6989 6997
40. H. Eggers, S. Steffens, A. Grosshennig, J.U. Becker, J. Hennenlotter, and A. Stenzl Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma Int J Oncol 40 2012 1650 1658
41. I. Peters, H. Eggers, F. Atschekzei, J. Hennelotter, S. Waalkes, and W. Tränkeschuh GATA5 CpG island methylation in renal cell cancer: A potential biomarker for metastasis and disease progresion BJUI Int 110 2012 144 152
42. J.E. Breault, H. Shiina, M. Igawa, L.A. Ribeiro-Filho, M. Deguchi, and H. Enokida Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma Clin Cancer Res 11 2005 557 564
43. M. Brait, L. Maldonado, S. Begum, M. Loyo, D. Wehle, and F.F. Tavora DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma Br J Cancer 106 2012 414 423
44. J. Ellinger, P. Albers, F.G. Perabo, S.C. Muller, A. von Ruecker, and P.J. Bastian CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer J Urol 182 2009 324 329
45. T. Kawakami, K. Okamoto, O. Ogawa, and Y. Okada XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer Lancet 363 2004 40 42